易操作的临床特征与生物标志物助力肠易激综合征管理
肠易激综合征(IBS)是基于症状模式诊断的脑-肠互动障碍,现有Rome IV标准无法识别个体病理生理机制,导致治疗常需试错。本文讨论如何纳入额外临床特征和可操作生物标志物,以指导IBS初始治疗选择,推动个体化医疗,提高效率和疗效。
要点
- IBS目前按症状模式分型治疗,但仅部分患者对现有干预有反应。
- Rome IV标准有助于诊断,但无法识别个体化病理生理机制。
- 结合临床特征和可操作生物标志物可优化初始治疗选择。
核心结论
- 在IBS诊疗中纳入额外临床特征和可操作生物标志物,可帮助临床医生更好地初始选择治疗,实现更高效、更有效的个体化医疗。
研究设计与样本
- 本文为综述/观点文章,讨论在IBS临床 care 中整合临床特征和生物标志物以指导治疗选择。
主要发现
- IBS由症状模式定义,大多数临床 care 依赖按IBS亚型指导的治疗。
- 生物心理社会模型和Rome IV标准推进了诊断,但未识别任一患者中起作用的特定病理生理机制。
- 多数IBS干预仅使部分患者获益,患者常需经历一系列试错方法管理症状。
临床怎么用
- 临床医生可考虑在初始治疗选择时,结合额外临床特征和可操作生物标志物进行个体化决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Irritable bowel syndrome (IBS) is a common, chronic disorder of gut-brain interaction that is characterized by core clinical features of abdominal pain and altered bowel movements. Because IBS remains defined by symptom patterns, most clinical care for patients with IBS relies on treatments directed by IBS subtype. Although the biopsychosocial model has advanced disorder of gut-brain interaction research and clinical care, and the current Rome IV criteria have greatly helped the diagnostic paradigm for IBS, the model does not identify specific pathophysiological mechanisms that operate in any one patient. Consequently, most interventions for IBS benefit only subsets of patients, and patients often progress through a series of trial and error approaches to manage their IBS symptoms. There is a major clinical need to develop a practical basis for a personalized medicine approach in IBS care. In this article, we discuss how clinicians may incorporate additional clinical features and actionable biomarkers to better inform the initial choice of therapy for patients with IBS. Ideally, such a mechanistic approach should be more efficient, and ultimately more effective, leading to improved patient satisfaction and clinical outcomes.
引用
- Shin A, Staller K, Levinthal DJ, et al. Actionable Clinical Features and Biomarkers to Facilitate the Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2025. PMID: 41257528. doi:10.14309/ajg.0000000000003859
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。